All In Biotech

NDA 019487 · Kenvue Brands

Imodium A-D

Loperamide Hydrochloride · Oral

Last checked: Nov 19, 2026Latest source record: Aug 7, 2019 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1988

Mar 1, 1988

Approved uses

2

Original approval plus efficacy supplements

Registered trials

97

20 Phase 3, 11 recruiting

FAERS reports

44,941

27,585 serious, 3,911 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

From the label in effect Sep 23, 2025.

Use controls symptoms of diarrhea, including Travelers' Diarrhea

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Nov 23, 1992 Supplement 7 · Efficacy
  • Mar 1, 1988 Original approval · Type 5 - New Formulation or New Manufacturer
2 products under this application
  • IMODIUM A-D · LOPERAMIDE HYDROCHLORIDE 1MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · SOLUTION, ORAL · Discontinued
  • IMODIUM A-D · LOPERAMIDE HYDROCHLORIDE 1MG/7.5ML · SOLUTION, ORAL · Over-the-counter

Clinical trials

Interventional ClinicalTrials.gov studies with "Loperamide" as an intervention, any sponsor and status, largest first.

All 97 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • diarrhoea8,976
  • nausea4,323
  • drug ineffective4,099
  • fatigue3,916
  • off label use3,251
  • vomiting2,788
  • constipation2,503
  • weight decreased2,103
  • headache2,046
  • dyspnoea2,020
  • decreased appetite1,843
  • asthenia1,839

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
2004355
2005383
2006393
2007439
2008529
2009595
2010639
2011654
20121,057
2013948
20141,140
20153,461
20162,284
20173,131
20183,200
20193,186
20203,123
20212,864
20223,372
20233,683
20243,569
20253,540
20262,393

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 306 on PubMed

Sponsor: Kenvue Brands

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.